STAT+: Pharmalittle: Seagen CEO under investigation after alleged domestic violence; Bausch & Lomb settles for a lesser IPO

Good morning, one and all. Damian Garde here, filling in for Ed Silverman on another day of what passes for spring in the northeast U.S. So begins another working week of deadlines, meetings, and internal debates on the etiquette of leaving your camera off for the day’s umpteenth Zoom. Here as always are a few tidbits to get your day started. Do let us know if you hear something interesting. …

The CEO of Seagen, formerly known as Seattle Genetics, is on a leave of absence following an alleged incident of domestic violence, the company said. Clay Siegall, who also serves as chairman, has denied the allegations, according to Seagen. The company is conducting its own investigation and has appointed an interim CEO in the meantime.

Continue to STAT+ to read the full story…